v3.26.3
SEMPRA - EQUITY AND EARNINGS PER COMMON SHARE - EARNINGS PER COMMON SHARE (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Earnings attributable to common shares, basic $ 877 $ 77 $ 2,710 $ 1,444
Earnings attributable to common shares, diluted $ 877 $ 77 $ 2,710 $ 1,444
Weighted-average common shares outstanding for basic EPS (in shares) 654,262,000 652,948,000 653,966,000 652,538,000
Dilutive effect of common shares sold forward (in shares) 396,000 267,000 465,000 123,000
Dilutive effect of stock options and RSUs (in shares) 1,281,000 794,000 1,362,000 759,000
Weighted-average common shares outstanding for diluted EPS (in shares) 655,939,000 654,009,000 655,793,000 653,420,000
Earnings per share, basic (in dollars per share) $ 1.34 $ 0.12 $ 4.14 $ 2.21
Earnings per share, diluted (in dollars per share) $ 1.34 $ 0.12 $ 4.13 $ 2.21
Vested RSUs included in basic WASO (in shares) 368,000 492,000 373,000 502,000
Stock options, RSAs and RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Non-qualified stock options granted (in shares)     568,052  
Performance-based RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Equity awards, granted (in shares)     441,749  
Service-based RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Equity awards, granted (in shares)     197,314  
Stock options, RSAs and RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Antidilutive securities excluded from earnings per share (in shares) 908,615 331,462 688,634 743,454